SEC Form 4 · accession 0001179110-18-005927
MOMENTA PHARMACEUTICALS INC · MNTA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Elizabeth Stoner
Director
Period of report
Apr 25, 2018
Accepted (ET)
Apr 27, 2018 · 4:22 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001235010
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 25, 2018 | M | 20 | $12.34 | A | 21,684 | D | |
| Common Stock | Apr 25, 2018 | S | 15 | $20.00 | D | 21,669 | D | |
| Common Stock | Apr 26, 2018 | M | 4,980 | $12.34 | A | 26,649 | D | |
| Common Stock | Apr 26, 2018 | S | 3,842 | $20.00 | D | 22,807 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $12.34 | Apr 25, 2018 | M | 20 | D | Jun 10, 2011 | Jun 10, 2020 | Common Stock | 20 | 4,980 | D |
| Stock Option (Right to Buy) | $12.34 | Apr 26, 2018 | M | 4,980 | D | Jun 10, 2011 | Jun 10, 2020 | Common Stock | 4,980 | 0 | D |
Explanation of responses
- F1This transaction was effected pursuant to a Rule 10b5-1 trading plan.